title: Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides.
abstract: Unmethylated CpG oligodeoxynucleotides (ODNs), by activating cells of the innate immune system, such as dendritic cells and NK cells, are potent adjuvants for type 1 immune responses. In the present study, we aimed to investigate the role of invariant NKT (iNKT) cells, a subset of lipid-reactive innate lymphocytes, in CpG ODN-induced innate and acquired type 1 responses. Our data show that, in response to the CpG ODN type B 1826, splenic and hepatic iNKT cells become activated and produce IFN-gamma, but not IL-4, both in vitro and in vivo. This Th1 bias is independent from the Ag-presenting molecule CD1d and strongly requires IL-12, at least in vitro. We also report that iNKT cell activation, in response to CpG ODN type B, results in the transactivation of NK cells. To address the potential role of iNKT cells in type 1 innate immunity induced by CpG ODN, a murine model of malignant melanoma was used. We show that CpG ODN type B protects mice against B16F10-induced lung metastasis in wild-type mice, but in a less efficient manner in iNKT cell-deficient animals. Finally, we report that immunization of wild-type mice with CpG ODN type B plus keyhole limpet hemocyanin biases the immune response toward a Th1 direction, an effect strongly mediated by iNKT cells. We conclude that iNKT cells amplify the innate and acquired response to CpG ODN type B, with potentially important consequences for the regulation of immune responses.
authors.affiliation: Institut National de Santé et de Recherche Médicale, Unité 547, Lille, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Paget
authors.forename: Emilie
authors.initials: E
authors.lastname: Bialecki
authors.forename: Josette
authors.initials: J
authors.lastname: Fontaine
authors.forename: Catherine
authors.initials: C
authors.lastname: Vendeville
authors.forename: Thierry
authors.initials: T
authors.lastname: Mallevaey
authors.forename: Christelle
authors.initials: C
authors.lastname: Faveeuw
authors.forename: François
authors.initials: F
authors.lastname: Trottein
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D004247:DNA / Q000276:immunology* / Q000494:pharmacology; D005260:Female; D007371:Interferon-gamma / Q000096:biosynthesis / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology*; D008546:Melanoma, Experimental / Q000276:immunology; D051379:Mice; D055611:Natural Killer T-Cells / Q000276:immunology*; D009838:Oligodeoxyribonucleotides; D018417:Th1 Cells / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; C423449:CpG ODN 1826; D009838:Oligodeoxyribonucleotides; D007371:Interferon-gamma; D004247:DNA